FDA NDC Directory · JSON-LD · Markdown

Liothyronine Sodium

NDC 87063-082 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerASCLEMED USA INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA200295
Dosage form / routeTABLET · ORAL
Active ingredientsLIOTHYRONINE SODIUM (50 ug/1)
Marketing started20121203
Package count4

External sources

Source: openFDA. Public-domain (CC0).